In vivo experiments revealed that this engineered bacterial system exhibited excellent tumor targeting and penetration effects in CDH17‐positive solid tumors, including desmoplastic stroma‐enriched pancreatic cancer. The gene discussed is CDH17; the disease is neoplasm.